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Abstract
Background Clinical and biochemical impacts on liver 
dysfunction, as manifested by an increase in serum transaminase 
levels, are common in dengue infection. However, an association of 
elevated serum transaminase and dengue shock syndrome (DSS) 
has not been well-established. 
ObjectiveTo assess for an association between serum transaminase 
levels and the presence of DSS in children.
Methods A nested, case control study was conducted on children 
DJHGPRQWKWR\HDUVDGPLWWHGWR6DQJODK+RVSLWDOZKR
were diagnosed with dengue infection. Baseline characteristics 
DQGVHUXPWUDQVDPLQDVHOHYHOVZHUHUHFRUGHG3DWLHQWVZKRZHUH
included in the study were observed for the presence of DSS. 
Those who had DSS were selected as cases, and those who did not 
develop DSS were selected as controls. Data was analyzed using 
ELYDULDWHDQGPXOWLYDULDWHPHWKRGVZLWKFRQILGHQFHLQWHUYDOV
DQG3YDOXHZDVFRQVLGHUHGDVVWDWLVWLFDOO\VLJQLILFDQW
Results Ninety-four children were involeved, 47 children in the 
case group and the other 47 were in the control group. Baseline
FKDUDFWHULVWLFVRIWKHVXEMHFWVZHUHVLPLODUEHWZHHQWKHFDVHDQG
control groups. Serum aspartate transaminase (AST) level of 
8/DQGDODQLQHWUDQVDPLQDVH$/7RI8/ZHUH
DVVRFLDWHGZLWK'6625&,WR3 DQG
25&,WR3 UHVSHFWLYHO\
Conclusion Elevated AST and ALT levels were associated 
with an increased risk of DSS in children with dengue infection. 
[Paediatr Indones. 2014;54:181-5.].
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D
engue is a mosquito-borne viral disease 
with the most rapid spread in the world. It 
LVDPDMRUFDXVHRIPRUELGLW\DQGPRUWDOLW\
in Southeast Asia. Disease severity ranges 
from undifferentiated acute febrile illness to dengue 
fever (DF) to dengue hemorrhagic fever (DHF) to 
dengue shock syndrome (DSS), which is associated 
with a degree of plasma leakage.3 Dengue may 
occasionally affect other body systems. The liver is a 
target organ of the Dengue virus.4 Hepatic dysfunction 
is common in dengue infection, and is attributed to 
a direct viral effect on liver cells or as a consequence 
of dysregulated host immune responses against the 
virus.5 Hepatic dysfunction may be reflected by 
elevated transaminase levels, which may range from 
mild to severe.4
Studies on transaminase levels have been 
reported and show varying results. Elevation 
of aspartate transaminase (AST) and alanine 
transaminase (ALT) levels were significantly different 
in DF, DHF, and DSS patients in some studies,
while other studies showed no significant difference Yoga Putra et al: Serum transaminase levels and dengue shock syndrome in children
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in transaminase levels.Therefore, we evaluated 
for a possible association between serum transaminase 
levels and DSS in children. 
Methods
A nested, case-control study was conducted in 
FKLOGUHQZLWKGHQJXHLQIHFWLRQDJHGPRQWKWR
years admitted to the Department of Child Health, 
8GD\DQD8QLYHUVLW\0HGLFDO6FKRRO6DQJODK+RVSLWDO
'HQSDVDUIURP-XQHWR0DUFK
We included all children with a diagnosis of 
suspected dengue infection according to the WHO
FULWHULD3DWLHQWVGLDJQRVHGZLWKPDOLJQDQFLHV
immune disorders, hemato-oncology disorders, or 
KDGDKLVWRU\RIKHSDWLWLVZHUHH[FOXGHG:HDOVR
H[FOXGHGSDWLHQWVZKRPZHZHUHXQDEOHWRREVHUYH
such as those who died or were referred to another 
KRVSLWDO3DWLHQWVZHUHREVHUYHGIRUSUHVXPHG'66
during treatment according to standard medical care 
IRUGHQJXHLQIHFWLRQ3DWLHQWVZKRKDG'66ZHUH
selected as cases and those who did not develop DSS 
(DF, DHF I, and DHF II) were selected as controls. 
At the admission, in addition to routine blood 
H[DPLQDWLRQVDOOSDWLHQWV·EORRGVHUXPZHUHWDNHQ
coded and stored. Serum transaminase level then 
evaluated if patient met the criteria as case or control. 
:HREWDLQHGVXEMHFWV·KLVWRULHVLQFOXGLQJGXUDWLRQ
of fever, presence of abdominal pain, vomiting, and 
bleeding. 
6HUXPWUDQVDPLQDVHOHYHOVZHUHH[DPLQGHG
on the first day of admission. Hematocrit, leukocyte 
count, hemoglobin, and platelet measurements 
were obtained from blood counts with the highest 
hematocrit was taken as a baseline value on the first 
day of admission. This study was approved by the 
Research Ethics Committee of Udayana University
0HGLFDO6FKRRO6DQJODK+RVSLWDO'HQSDVDU
A minimum required sample size was calculated 
for an unpaired, case control study, according to 
assumed odds ratios (OR) of each variable (AST and 
ALT). The sample size calculated using the highest 
25RI$67ZLWKDW\SH,HUURURIDQGSRZHURI
ZDVVXEMHFWVLQHDFKJURXS'DWDZDVDQDO\]HG
separately for each factor by bivariate analysis (Chi-
square test and unpaired T-test). Multivariate analysis 
was performed using backward logistic regression 
/55HVXOWVDUHSUHVHQWHGLQ25ZLWK
confidence intervals, and a statistical significance 
YDOXHRI3
Results
'XULQJWKHVWXG\SHULRGFKLOGUHQZLWKVXVSHFWHG
dengue infection were admitted in Sanglah Hospital. 
7ZRSDWLHQWVLQWKLVVWXG\ZHUHH[FOXGHGEHFDXVH
they had history of hepatitis. During observation, 47 
SDWLHQWVZLWK'66ZHUHDVVLJQHGDVFDVHV6L[W\FKLOGUHQ
GLGQRWH[SHULHQFHVKRFNDQGRXWRIWKHVHZHUH
consecutively selected as the control based on the 
GXUDWLRQRIIHYHUDWWKHWLPHRIDGPLVVLRQ6XEMHFWV·
DJHVUDQJHGIURPPRQWKVWR\HDUV%DVHOLQH
FKDUDFWHULVWLFVRIWKHVXEMHFWVDQGYDULDEOHVDVVRFLDWHG
with DSS in children are shown in Table 1.
Based on multivariate analysis, variables associ-
ated with DSS were liver enlargement (hepatomegaly), 
DEGRPLQDOSDLQKHPDWRFULWOHYHO$67OHYHO
8/DQG$/7OHYHO8/Table 2). 
Based on the multivariate analysis, we deter-
PLQHGWKHULVNRI'66EDVHGRQ$67OHYHO>25
&,WR3 @DVVKRZQLQTable 
3DQG$/7OHYHO>25&,WR
3 @DVVKRZQLQTable 4.
Based on Table 3, every patient with dengue 
infection who were found with abdominal pain, 
KHSDWRPHJDO\KHPDWRFULWDQG$67
8/KDGDSUREDELOLW\RI'66RIDVKLJKDV
In patients with abdominal pain, hepatomegaly, 
KHPDWRFULWDQG$678/WKH
SUREDELOLW\RI'66ZDVDVKLJKDV3DWLHQWVZLWK
dengue infection and abdominal pain, hepatomegaly, 
KHPDWRFULWDQG$678/KDG
DSUREDELOLW\RI'66RI,QSDWLHQWVZLWK
DEGRPLQDOSDLQDQG$678/WKH'66
SUREDELOLW\ZDVZKLOHLIDEGRPLQDOSDLQDORQH
ZDVIRXQGWKHSUREDELOLW\IRU'66ZDVRQO\
Based on Table 4, in patients with dengue 
infection who were found to have abdominal pain, 
KHSDWRPHJDO\KHPDWRFULWDQG$/7
8/WKHLUSUREDELOLW\RIKDYLQJ'66ZDV
In patients with abdominal pain, hepatomegaly, 
KHPDWRFULWDQG$/78/WKHSUREDELOLW\
RIKDYLQJ'66ZDV)XUWKHUPRUHLISDWLHQWV
KDGDEGRPLQDOSDLQKHSDWRPHJDO\KHPDWRFULWYoga Putra et al: Serum transaminase levels and dengue shock syndrome in children
Paediatr Indones, Vol. 54, No. 3, May 2014183
Table 1. Characteristics of study subjects and bivariate analyses of variables associated with dengue shock 
syndrome
Characteristics
DSS group
(n = 47)
Non-DSS group
(n= 47)
P value OR 95%CI
Mean age (SD), months 75.5 (36.9)  88 (35.3) 0.79*
Gender, n (%) 1.29
Male 26    (55) 23 (49) 0.536 0.57 to 2.9
Female 21    (45) 24 (51)
Nutritional status, n (%)
Underweight
Normal weight
Overweight
12    (26)
24    (51)
11    (23)
  9 (19)
32 (68)
  6 (13)
0.268
Mean duration of fever at admission (SD), days   4.3 (0.73)   4.5 (0.8)  0.569*
%NKPKECNſPFKPIUP

Petechiae 10    (21) 11 (23)
Epistaxis   6    (13)   4 (9) 0.503 1.57 0.4 to 5.98
Hepatomegaly 35    (75) 14 (30) 0.000 6.8 2.78 to 17
Abdominal pain 37    (79) 12 (26) 0.000 10.8 4.1 to 28
Nausea and vomiting 25    (53) 22 (47) 0.536 1.29 0.57 to 2.9
Leucocytes count, n (%)
ŭz.
>4000/μL
12    (26)
35    (75)
23 (49)
24 (51)
0.019 0.36 0.2 to 0.85
Hemoglobin, n (%)
ŮIF.
<14 g/dL
45    (96)
  2    (4)
23 (49)
24 (51)
0.000 23.4 5.1 to 188
 Hematocrit, n (%)
Ů
<46 %
34    (72)
13    (28)
  3 (6)
44 (94)
0.000 38.4 10 to 145.4
Platelets count, n (%)
ŭz.
>50,000/μL
30    (64)
17    (36)
34 (72)
13 (28)
0.376 0.68 0.3 to 1.6
Serology, n (%)
IgG and IgM positive
IgG or IgM positive
37    (79)
10    (21)
34 (72)
13 (28)
0.472 1.4 0.5 to 42.8
Transaminase levels (IU/L)
AST, n (%)
Ů+7.
<128.5 IU/L
37 (79)
10 (21)
9 (19)
38 (81)
0.000 15.6 5.7 to 42.8
ALT, n (%)
Ů+7.
<40 IU/L
20 (43)
27 (58)
2 (4)
45 (96)
0.000 8.46 3 to 23.7
Mean length of hospital stay (SD), days  4.7 (1) 3.15 (1)
 *Unpaired T-test
Table 2. Multivariate analysis of variables associated with DSS
Step Variables     B     OR P value       95% CI
Step 1 Hepatomegaly  2.154   8.620 0.023 1.35 to   55.10
Abdominal pain  1.742   5.709 0.04 1.08 to   30.19
.GWEQE[VGŭz. -1.168   0.311 0.262 0.04 to     2.40
*GOCVQETKVŮ  2.289 13.313 0.011 1.8   to   98.66
*GOQINQDKPŮIF.  2.219   9.198 0.007 0.84 to 100.98
#56Ů+7.  2.374 10.739 0.008 1.85 to   62.38
#.6Ů+7.  1.859   6.42 0.047 1.03 to   40.10
Constant -5.956
Step 2 Hepatomegaly  1.959   7.094 0.027 1.25 to   40.23
Abdominal pain  1.911   6.763 0.023 1.3   to   35.33
*GOCVQETKVŮ  2.651 14.166 0.012 1.80 to 111.43
*GOQINQDKPŮIF.  2.086   8.05 0.056 0.95 to   68.15
#56Ů+7.  2.206   9.082 0.01 1.70 to   48.41
#.6Ů+7.  1.859   7.402 0.03 1.22 to   45.02
Constant -6.146Yoga Putra et al: Serum transaminase levels and dengue shock syndrome in children
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DQG$/78/WKHSUREDELOLW\RI'66ZDV
When patients were found with abdominal pain and 
$/78/'66SUREDELOLW\ZDV
Discussion
Liver damage with elevated serum transaminase 
levels is a common complication of dengue virus 
infection. Therefore, measurement of serum AST 
and ALT levels are required to determine liver 
involvement.6 Our results were consistent with that 
of previous studies. Sutriani et al. reported an 
association between AST level and DSS, with an OR
RI&,WRZKLOH$/7OHYHO
was not statistically significant associated to DSS.5
Differences in results were likely due to different 
cut-off points used for transaminase levels (AST 
!8/DQG$/7!8/GLIIHUHQWWLPHVDW
which serum samples were taken for transaminase 
H[DPLQDWLRQDQGH[FOXVLRQRISDWLHQWVZLWKIHYHU
GD\V6HUXPWUDQVDPLQDVHOHYHOVEHJLQWRULVHRQ
the third day of fever, reaching the highest level on 
the ninth day of illness, then decreasing gradually 
LQZHHNV
Several studies had contrasting results with no 
association between increased transaminase level 
and the clinical spectrum of dengue infection.
This difference is likely due to different cut-off points 
for the AST and ALT levels used in each study. A 
Vietnamese study reported that elevations in AST 
and ALT levels were significantly different in DHF II 
and DHF IV, and elevations of serum transaminase 
levels in DHF ranged from mild to moderate (less 
than five times from the normal value).  The study 
showed increased ALT levels of more than five times 
in patients with severe dengue infection. The liver 
damage that occurs is not a primary process of dengue 
virus infection, but may be due to shock, which leads 
to ischemia in the liver cells.Elevation of serum 
transaminase levels in dengue infection is temporary 
and will gradually decrease to normal after two to 
three weeks.7
The mechanism of liver involvement in dengue 
infection is not entirely clear. Liver cell damage may 
be due to one or more of the following mechanisms: 
GLUHFWF\WRSDWKLFHIIHFWVRIWKHYLUXVGHDWK
of infected liver cells induced by cells of the immune 
system, and (3) non-specific effects of shock and 
hypotension. Dengue infection may lead to the 
following liver histology changes: microvesicular 
steatosis, hepatocellular necrosis, destruction and 
K\SHUSODVLDRI.XSIIHUFHOOVDQGFHOOXODULQILOWUDWHVLQ
the portal tract. Necrosis of liver cells is generally 
found in the mid- and centro-lobular zones, possibly 
GXHWRKLJKHUVHQVLWLYLW\RIOLYHUFHOOVWRDQR[LDRU
cytokines in these regions.
In this study, based on multivariate analysis, 
we created prognostic models to determine the 
probability of the occurrence of DSS if these variables 
were found simultaneously in patients with dengue 
LQIHFWLRQ3URJQRVWLFPRGHOVLQTable 3 consisted of 
DEGRPLQDOSDLQKHSDWRPHJDO\KHPDWRFULW
DQG$678/7KHSURJQRVWLFPRGHOVLQ
Table 3. Multivariate analysis of AST level associated with DSS 
Step Variables      B OR P value     95%CI
Step 1 Abdominal pain  2.083   8.1 0.005 1.9 to   34.7
Hepatomegaly  1.834   6.3 0.015 1.4 to   27.6
*GOCVQETKVŮ
#56Ů+7.
 3.153
 2.303
23.4
10
0.000
0.002
4    to 135.7
2.3 to   44.4
Constant -4.091
Table 4. Multivariate analysis of ALT level associated with DSS
Step Variables     B  OR P value     95%CI
Step 1 Abdominal pain  2.087   8.1 0.005 1.9 to   34.1
Hepatomegaly  1.879   6.6 0.011 1.5 to   28.1
*GOCVQETKVŮ
#.6Ů+7.
 3.376
 1.991
29.3
  7.3
0.000
0.009
5.5 to 156.3
1.6 to   32.9
Constant -3.910Yoga Putra et al: Serum transaminase levels and dengue shock syndrome in children
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Table 4 consisted of abdominal pain, hepatomegaly, 
KHPDWRFULWDQG$/78/
7KHGHJUHHRIKHSDWLFLQMXU\LQFUHDVHGWUDQVD
minase levels) has been strongly associated with the 
presence of severe complications of dengue infection. 
7KHUHIRUHDWDPLQLPXPWUDQVDPLQDVHH[DPLQDWLRQV
should be performed regularly during follow-up of 
dengue patients.Understanding of variables related 
to DSS should make physicians more alert to early 
signs of DSS. Although plasma leakage and bleeding 
cannot be prevented, deterioration into DSS may 
be prevented with close monitoring for early signs of 
shock and adequate fluid therapy.
/LPLWDWLRQVWRRXUVWXG\LQFOXGHGWKHH[FOXVLRQ
of patients with a history of hepatitis only by history-
WDNLQJDQGWUDQVDPLQDVHH[DPLQDWLRQVSHUIRUPHGRQO\
once at the time of admission. Future studies should 
be conducted using the cohort method with serial 
WUDQVDPLQDVHH[DPLQDWLRQVWRGHWHUPLQHDFDXVDO
relationship between serum transaminase levels and 
severity of dengue infection. 
In conclusion, elevated serum transaminase is 
associated with increased risk of DSS in children 
with dengue infection. In addition, abdominal pain, 
KHSDWRPHJDO\DQGKHPDWRFULWOHYHORIPD\
also be associated with increased risk for DSS.
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